✦ LIBER ✦

Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial

✍ Scribed by Horvath, Christopher; Andrews, Laura; Baumann, Andreas; Black, Lauren; Blanset, Diann; Cavagnaro, Joy; Hastings, Kenneth L.; Hutto, David L.; MacLachlan, Timothy K.; Milton, Mark; Reynolds, Theresa; Roberts, Stan; Rogge, Mark; Sims, Jennifer; Treacy, George; Warner, Garvin; Green, James D.

Book ID: 118214351
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 118 KB
Volume: 12
Category: Article
ISSN: 1474-1741
DOI: 10.1038/nri3192-c1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The storm has cleared: lessons from the

The storm has cleared: lessons from the CD28 superagonist TGN1412 trial

✍ Hünig, Thomas 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

Some aspects of the recombinantly expres

Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials

✍ Jitendra N. Mehrishi; Miklós Szabó; Tibor Bakács 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 837 KB

Cytokine Storm in a Phase 1 Trial of the

Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

✍ Suntharalingam, Ganesh; Perry, Meghan R.; Ward, Stephen; Brett, Stephen J.; Cast 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 402 KB